Presented By Dr Sylvie Lorenzen, Rechts der Isar Hospital, Germany Trial Phase 2, IKF-AIO-Moonlight Conference ESMO 2024 Type Peer-reviewed article
4 November 2024 13:08
Presented By Dr Myriam Chalabi, Netherlands Cancer Institute, the Netherlands; Dr Peter de Gooyer, Netherlands Cancer Institute, the Netherlands Trial Phase 2, NICHE Conference ESMO 2024 Type Peer-reviewed article
4 November 2024 13:00
Presented By Dr Iris Nederlof, Netherlands Cancer Institute, the Netherlands Trial Phase 2, BELLINI Conference ESMO 2024 Type Peer-reviewed article
4 November 2024 12:35
Presented By Dr Minke Lucas, Netherlands Cancer Institute, the Netherlands Trial Phase 3, NADINA Conference ESMO 2024 Type Peer-reviewed article
4 November 2024 12:00
Trial Phase 3, KEYNOTE-006, CheckMate 067 Conference ESMO 2024 Type Peer-reviewed article
4 November 2024 11:53
Trial LITESPARK-005, SUNNIFORECAST Type Peer-reviewed article
4 November 2024 11:42
Presented By Prof. Bradley Monk, University of Arizona, AZ, USA Trial Phase 3, ATHENA-COMBO Conference ESMO 2024 Type Peer-reviewed article
4 November 2024 11:25
Presented By Dr Sara Lonardi, Veneto Institute of Oncology, Italy Trial Phase 3, CheckMate 8HW Conference ESMO GI 2024 Type Peer-reviewed article
21 August 2024 11:39
Presented By Dr Francesco Sclafani, Institut Jules Bordet, Belgium Trial Phase 2, REGINA Conference ESMO GI 2024 Type Peer-reviewed article
21 August 2024 11:34
Trial Phase 2, ECOG-ACRIN EA2201 Type Peer-reviewed article
21 August 2024 11:19
Presented By Prof. Heinz-Josef Lenz, University of Southern California Norris Comprehensive Cancer Center, CA, USA Trial Phase 3, CheckMate 8HW Conference ASCO 2024 Type Peer-reviewed article
18 July 2024 15:44
Trial Phase 1/2, NICHE-2, NEOPRISM-CRC Conference ASCO 2024 Type Peer-reviewed article
18 July 2024 15:36
Presented By Dr Peter Galle, Universitätsmedizin Mainz, Germany Trial Phase 3, CheckMate 9DW Conference ASCO 2024 Type Peer-reviewed article
18 July 2024 15:10
Presented By Prof. Christian Blank, Antoni van Leeuwenhoek, the Netherlands Trial Phase 3, NADINA Conference ASCO 2024 Type Peer-reviewed article
18 July 2024 14:16
Presented By Prof. Matthew Galsky, Tisch Cancer Institute, NY, USA Trial Phase 3, CheckMate 901 Conference ASCO 2024 Type Peer-reviewed article
18 July 2024 13:48
Expert Dr Saby George, Roswell Park Cancer Institute, Buffalo, NY, USA Trial Phase 3, CheckMate 67T Conference ASCO GU 2024
17 July 2024 12:37
Presented By Prof. Ian Chau, Royal Marsden Hospital, UK Trial Phase 3, CheckMate 648 Conference ASCO GI 2024 Type News article
13 February 2024 14:13
Presented By Dr Kohei Shitara, National Cancer Center Hospital East, Japan Trial Phase 3, CheckMate 649 Conference ASCO GI 2024 Type News article
13 February 2024 14:03
Presented By Prof. Thierry André, Sorbonne University, France Trial Phase 3, CheckMate 8HW Conference ASCO GI 2024 Type News article
13 February 2024 12:44
Presented By Dr Sherene Loi, Peter MacCallum Cancer Centre, Australia Trial Phase 3, CheckMate 7FL Conference SABCS 2023 Type News article
11 January 2024 15:02
Presented By Dr Nicholas Zdenkowski, University of Newcastle, Australia Trial Phase 2, Neo-N Conference SABCS 2023 Type News article
11 January 2024 14:57
Presented By Dr Yara Verschoor, Netherlands Cancer Institute, the Netherlands Trial Phase 2, NICHE-3 Conference ESMO 2023 Type Peer-reviewed article
18 December 2023 16:04
Presented By Prof. Georgina Long, University of Sydney, Australia Trial Phase 3, CheckMate76K Conference ASCO 2023 Type Peer-reviewed article
2 August 2023 09:27
Presented By Prof. Alex Herrera, City of Hope Medical Center, CA, USA Trial Phase 3, SWOG S1826 Conference ASCO 2023 Type Peer-reviewed article
1 August 2023 12:38
Presented By Dr Anna Sureda, Catalan Institute of Oncology, Spain Conference EBMT 2023 Type Peer-reviewed article
15 June 2023 17:15
Presented By Dr Yelena Janjigian, Memorial Sloan Kettering Cancer, NY, USA Trial Phase 3, CheckMate 649 Conference ASCO GI 2023 Type Peer-reviewed article
17 March 2023 08:10
Presented By Dr Ken Kato, National Cancer Center Hospital, Japan Trial Phase 3, CheckMate 648 Conference ASCO GI 2023 Type Peer-reviewed article
17 March 2023 08:02
Presented By Prof. Robert Motzer, Memorial Sloan Kettering Cancer Center, NY, USA Trial Phase 3, CheckMate 914 Conference ESMO 2022 Type Peer-reviewed article
17 November 2022 00:46
Presented By Prof Toni Choueiri, Dana-Farber Cancer Institute, MA, USA Trial Phase 3, COSMIC-313 Conference ESMO 2022 Type Peer-reviewed article
17 November 2022 00:41
Presented By Prof. Marleen Kok, Netherlands Cancer Institute, the Netherlands) Trial Phase 2, BELLINI Conference ESMO 2022 Type Peer-reviewed article
16 November 2022 18:01
Presented By Prof. Sylvie Lorenzen, Klinikum rechts der Isar, TU München, Germany Trial Phase 2, Moonlight Conference ESMO 2022 Type Peer-reviewed article
16 November 2022 17:31
Presented By Ms Marta Casarrubios, Hospital Universitario Puerta de Hierro-Majadahonda, Spain Trial Phase 2, NADIM Conference WCLC 2022 Type News article
23 August 2022 10:55
Presented By Dr Mariano Provencio, Hospital Universitario Puerta de Hierro-Majadahonda, Spain Trial Phase 2, NADIM II Conference WCLC 2022 Type News article
23 August 2022 10:52
Presented By Prof. Bradley Monk, University of Arizona, AZ, USA Trial Phase 3, ATHENA-MONO Conference ASCO 2022 Type Peer-reviewed article
5 August 2022 15:28
Presented By Prof. Julie Brahmer, Sidney Kimmel Comprehensive Cancer Center, Australia Trial Phase 3, CheckMate 227 Conference ASCO 2022 Type Peer-reviewed article
5 August 2022 12:29
Presented By Dr Paul Bröckelmann, University Hospital of Cologne, Germany Trial Phase 2, AERN Conference EHA 2022 Type News article
1 July 2022 11:37
Presented By Dr Rachel Giles, Medicom Conference ELCC 2022
19 April 2022 10:43
Presented By Prof. Marc-Oliver Grimm, University Hospital Jena, Germany Trial Phase 2, TITAN-TCC Conference ASCO GU 2022 Type Peer-reviewed article
8 April 2022 11:17
Presented By Dr Marc-Oliver Grimm, University Hospital Jena, Germany Trial Phase 2, TITAN-RCC Conference ASCO GU 2022 Type Peer-reviewed article
8 April 2022 11:13
Presented By Dr Matthew Zibelman, Fox Chase Cancer Center, PA, USA Trial Phase 1/2 Conference ASCO GU 2022 Type Peer-reviewed article
8 April 2022 11:13
Presented By Dr Michael Atkins, Georgetown Lombardi Comprehensive Cancer Center, DC, USA Trial Phase 2, HCRN GU16-260 Conference ASCO GU 2022 Type Peer-reviewed article
8 April 2022 11:12
Presented By Dr Kohei Shitara, National Cancer Center Hospital East, Japan; Dr Yu Sunakawa, St. Marianna University School of Medicine, Japan Trial Phase 3, CheckMate 649, DELIVER Conference ASCO GI 2022 Type Peer-reviewed article
21 March 2022 11:11
Presented By Dr Romain Cohen, Sorbonne University, France Trial Phase 2, NIPICOL Conference ASCO GI 2022 Type Peer-reviewed article
21 March 2022 10:30
Presented By Dr Heinz-Josef Lenz, USC Norris Comprehensive Cancer Center, CA, USA Trial Phase 3, CheckMate 9X8 Conference ASCO GI 2022 Type Peer-reviewed article
21 March 2022 10:21
Presented By Dr Rachel Giles, Medicom Conference ASCO GI 2022
8 February 2022 12:37
Presented By Dr Romualdo Barroso-Sousa , Hospital Sírio-Libanês, Brazil Trial Phase 2, NIMBUS Conference SABCS 2021 Type Peer-reviewed article
31 January 2022 17:59
Presented By Dr Filippo Pietrantonio, Istituto Nazionale dei Tumori di Milano, Italy & Dr Chiara Cremolini, Azienda Ospedaliero-Universitaria Pisana, Italy Trial Phase 2, MAYA & AtezoTRIBE Conference ESMO 2021 Type Peer-reviewed article
19 November 2021 09:42
Presented By Dr Yelena Janjigian, Memorial Sloan Kettering Cancer Center, NY, USA Trial Phase 3, CheckMate649 Conference ESMO 2021 Type Peer-reviewed article
19 November 2021 09:41
Presented By Dr Alexander Stein, University Cancer Center Hamburg, Germany Trial Phase 2, INTEGA Conference ESMO 2021 Type Peer-reviewed article
19 November 2021 09:39
Presented By Prof. Solange Peters, Lausanne University Hospital, Switzerland Trial Phase 3, CheckMate743 Conference ESMO 2021 Type Peer-reviewed article
19 November 2021 09:36
Presented By Prof. Christian Blank, Netherlands Cancer Institute, the Netherlands Trial Phase 1, DONIMI Conference ESMO 2021 Type Peer-reviewed article
19 November 2021 09:30
Presented By Prof. Paolo Ascierto, Istituto Nazionale Tumori "Fondazione Pascale", Italy Trial Phase 2, SECOMBIT Conference ESMO 2021 Type Peer-reviewed article
19 November 2021 09:30
Presented By Dr Kim Margolin, City of Hope, CA, USA Trial Phase 2, CheckMate204 Conference ESMO 2021 Type Peer-reviewed article
19 November 2021 09:29
Presented By Dr Naveen Vasudev, St James University Hospital, UK Trial Phase 2, PRISM Conference ESMO 2021 Type Peer-reviewed article
19 November 2021 09:26
Presented By Dr Jeroen van Dorp, Netherlands Cancer Institute, the Netherlands Trial Phase 1, NABUCCO Conference ESMO 2021 Type Peer-reviewed article
19 November 2021 09:26
Presented By Dr Liudmila Fedorova, Pavlov University, Russia Conference ESMO 2021 Type Peer-reviewed article
19 November 2021 09:18
Presented By Dr Aman Chauhan, University of Kentucky, KY, USA Conference WCLC 2021 Type News article
21 September 2021 13:24
Presented By Prof. David Carbone, Ohio State University, USA Trial Phase 3, CheckMate 9LA Conference WCLC 2021 Type News article
21 September 2021 13:23
Presented By Dr Jonathan Spicer, McGill University, Canada Trial Phase 3, CheckMate 816 Conference ASCO 2021 Type Peer-reviewed article
12 August 2021 23:59
Presented By Dr Jedd Wolchok (Memorial Sloan Kettering Cancer Center, NY, USA). Prof. Reinhard Dummer (University Hospital Zürich, Switzerland) , Prof. Georgina Long (Melanoma Institute, Australia) Trial CheckMate 067, COLUMBUS, ABC Conference ASCO 2021 Type Peer-reviewed article
12 August 2021 23:10
Presented By Dr Evan Lipson, Johns Hopkins University, MD, USA Trial Phase 3, RELATIVITY-047 Conference ASCO 2021 Type Peer-reviewed article
12 August 2021 22:14
Presented By Prof. Martin Reck, Lung Clinic Grosshansdorf, Germany Trial Phase 3, CheckMate 9LA Conference ASCO 2021 Type Peer-reviewed article
12 August 2021 22:00
Presented By Dr Ian Chau, Royal Marsden Hospital, UK Trial Phase 3, CheckMate 648 Conference ASCO 2021 Type Peer-reviewed article
12 August 2021 20:12
Presented By Prof. Markus Moehler, Mainz University Clinic, Germany Trial Phase 3, CheckMate 649 Conference ASCO 2021 Type Peer-reviewed article
12 August 2021 19:15
Presented By Dr Rodabe Amaria , MD Anderson Cancer Center, TX, USA Trial Phase 2 Conference ASCO 2021 Type Peer-reviewed article
12 August 2021 12:16
Presented By Dr Marc André, Centre Hospitalier Universitaire UCL Namur, Belgium Trial CheckMate 205; KEYNOTE-087 Conference EHA 2021 Type Peer-reviewed article
5 August 2021 12:26
Presented By Prof. Taofeek Owonikoko, Emory University School of Medicine Trial KEYNOTE-604, ECOG-ACRIN EA5161 Journal Physician’s Weekly Conference ASCO20 Virtual Meeting
15 April 2021 16:03
Presented By Erika Hamilton, Sarah Cannon Research Institute at Tennessee Oncology in Nashville, TN Trial DESTINY-Breast01 Conference SABCS 2020
13 April 2021 17:11
Presented By Prof. Toni Choueiri , Dana Farber Cancer Institute, Harvard University, Boston, USA Trial Phase 3, CheckMate 9ER Journal Physician's Weekly Conference ESMO Virtual Congress 2020
13 April 2021 16:01
Presented By Dr. David Cella , Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, USA Trial Phase 3, CheckMate-9ER Journal Physician’s Weekly Conference ASCO GU 2021
13 April 2021 15:44
Presented By Prof. David Cella, Robert H. Lurie Comprehensive Cancer Centre, Northwestern University, Illinois, USA Trial Phase 3, CheckMate 9ER Conference ASCO GU 2021 Type Peer-reviewed article
24 March 2021 14:53
Presented By Prof. Yu Sunakawa, St Marianna University School of Medicine, Kanagawa, Japan Trial DELIVER Conference ASCO GI 2021 Type Peer-reviewed article
12 March 2021 11:47
Presented By Dr Michael Lee, University of Texas MD Anderson Cancer Center, USA Trial Phase 2 Conference ASCO GI 2021 Type Peer-reviewed article
12 March 2021 11:41
Presented By Prof. Eric Van Cutsem, University of Leuven, Belgium Trial Phase 3, CheckMate 577 Conference ASCO GI 2021 Type Peer-reviewed article
12 March 2021 11:40
Principal Investigator Prof. Toni Choueiri, Dana Farber Cancer Institute, Harvard University, Boston, USA Trial Phase 3, CheckMate 9ER Conference ESMO Virtual Congress 2020
15 December 2020 15:49
Conference ESMO 2020 Type Peer-reviewed article
25 November 2020 15:08
Conference ESMO 2020 Type Peer-reviewed article
25 November 2020 14:59
Conference ESMO 2020 Type Peer-reviewed article
25 November 2020 14:56
Conference ESMO 2020 Type Peer-reviewed article
25 November 2020 14:55
Conference ESMO 2020 Type Peer-reviewed article
25 November 2020 14:52
Conference ESMO 2020 Type Peer-reviewed article
25 November 2020 14:44
Conference ESMO 2020 Type Peer-reviewed article
25 November 2020 14:35
Presented By Prof. Christine Mauz-Körholz, Justus-Liebig-Universität Gießen, Germany Trial Phase 2, Checkmate 744 Conference EHA 2020 Type Peer-reviewed article
28 August 2020 12:09
Presented By Prof. Jennifer N. Choi, Northwestern Feinberg School of Medicine, USA Conference AAD 2020 Type Peer-reviewed article
6 August 2020 09:02
Presented By Prof. James Larkin, Royal Marsden NHS Foundation Trust, London, UK Trial Phase 3, CheckMate 067 Conference ESMO 2019 Type Peer-reviewed article
26 November 2019 23:06
Presented By Prof. Byoung Chul Cho, Yonsei University College of Medicine, South Korea Trial Phase 3, ATTRACTION-3 Conference ESMO 2019 Type Peer-reviewed article
26 November 2019 22:19
Presented By Prof. Jeffrey S. Weber, NYU Langone Medical Center, New York City, USA Trial Phase 3, CheckMate 238 Conference ESMO 2019 Type Peer-reviewed article
26 November 2019 22:15
Presented By Prof. Solange Peters, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland Trial Phase 3, CheckMate-227 Conference ESMO 2019 Type Peer-reviewed article
26 November 2019 22:05
Presented By Dr Thomas Yau, University of Hong Kong, China Trial Phase 3, CheckMate 459 Conference ESMO 2019 Type Peer-reviewed article
26 November 2019 20:21
Presented By Prof. Georgina Long, Melanoma Institute Australia, Sydney, Australia Trial ABC Conference ESMO 2019 Type Peer-reviewed article
26 November 2019 14:15
Presented By Prof. Scott Gettinger, Yale Cancer Center, USA Trial CheckMate 017, CheckMate 057 Conference WCLC 2019 Type Peer-reviewed article
8 November 2019 23:00
Presented By Dr Fabrice Barlesi, Hôpitaux de Marseille, France Trial Phase 4, CHECKMATE-817 Conference WCLC 2019 Type Peer-reviewed article
8 November 2019 21:15
Presented By Dr Tina Cascone, University of Texas MD Anderson Cancer Centre, USA Trial NEOSTAR Conference ASCO 2019 Type Peer-reviewed article
15 July 2019 23:59
Presented By Prof. Mario Mandalà, Papa Giovanni XXIII Cancer Centre Hospital, Bergamo, Italy Trial CheckMate 238 Conference ASCO 2019 Type Peer-reviewed article
15 July 2019 23:18
Presented By Prof. Bernhard Escudier, Gustave Roussy Cancer Campus, Paris, France Trial CheckMate 214 Conference ASCO 2019 Type Peer-reviewed article
15 July 2019 12:49
Trial Phase 3, CheckMate 067 Conference ASCO 2019 Type Peer-reviewed article
15 July 2019 12:45
Presented By Prof. Martin Reck, Airway Research Center North, Grosshansdorf, Germany Trial CheckMate 026, Keynote-024, Checkmate 227, MYSTIC, B-F1RST Conference ELCC 2019 Type Peer-reviewed article
25 June 2019 23:13
Presented By Dr Walter Weder, Dr Raffaele Califano Trial CALGB 9633 Conference ELCC 2019 Type Peer-reviewed article
25 June 2019 13:04
Presented By Dr Enriqueta Felip, Vall d’Hebron University Hospital, Spain Trial CA184-156, CheckMate-451, CASPIAN, Keynote-604, Checkmate 032 Conference ELCC 2019 Type Peer-reviewed article
25 June 2019 08:15
Trial Phase 3, CheckMate 227 Conference WCLC 2018 Type Peer-reviewed article
21 November 2018 23:44
